EV/EBITDA:
-13.55+0.06(+0.44%)Summary
- As of today, MLYS EV/EBITDA is -13.55, with a rise of +0.06 (+0.44%) during the current trading session.
- Over the past year, MLYS EV/EBITDA has dropped by -11.12 (-457.61%).
- MLYS EV/EBITDA is now -10523.08% below its all-time high of 0.13.
Performance
MLYS EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
MLYS EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise ValueEnterprise Value | PricePrice |
|---|---|---|---|
| 1D1 Day | +0.4% | -0.5% | -0.4% |
| 1M1 Month | -4.7% | +4.7% | +4.2% |
| 3M3 Months | -394.5% | +394.2% | +195.6% |
| 6M6 Months | -306.9% | +309.8% | +153.6% |
| YTDYTD | -527.3% | +562.5% | +222.0% |
| 1Y1 Year | -457.6% | +572.7% | +193.4% |
| 5Y5 Years | - | - | - |
MLYS EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs Highvs High | LowLow | Current vs Lowvs Low | |
|---|---|---|---|---|---|
| 1M | 1-Month | -12.72 | -6.5% | -15.27 | +11.3% |
| 3M | 3-Month | -2.60 | -421.1% | -15.27 | +11.3% |
| 6M | 6-Month | -2.60 | -421.1% | -15.27 | +11.3% |
| 1Y | 1-Year | -1.24 | -992.7% | -15.27 | +11.3% |
| 3Y | 3-Year | 0.13 | >-9999.0% | -28.10 | +51.8% |
| 5Y | 5-Year | 0.13 | >-9999.0% | -28.10 | +51.8% |
| All-Time | All-Time | 0.13 | >-9999.0% | -28.10 | +51.8% |
MLYS EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -13.55(-527.3%) |
| Date | Value |
|---|---|
| 2024 | -2.16(-56.5%) |
| 2023 | -1.38 |
FAQ
- What is Mineralys Therapeutics, Inc. EV/EBITDA?
- What is the all-time high EV/EBITDA for Mineralys Therapeutics, Inc.?
- What is MLYS EV/EBITDA year-to-date change?
- What is Mineralys Therapeutics, Inc. EV/EBITDA year-on-year change?
What is Mineralys Therapeutics, Inc. EV/EBITDA?
The current EV/EBITDA of MLYS is -13.55
What is the all-time high EV/EBITDA for Mineralys Therapeutics, Inc.?
Mineralys Therapeutics, Inc. all-time high EV/EBITDA is 0.13
What is MLYS EV/EBITDA year-to-date change?
Mineralys Therapeutics, Inc. EV/EBITDA has changed by -11.39 (-527.31%) since the beginning of the year
What is Mineralys Therapeutics, Inc. EV/EBITDA year-on-year change?
Over the past year, MLYS EV/EBITDA has changed by -11.12 (-457.61%)